Address: 26th Floor Rufino Tower, 6784 Ayala Avenue, Makati City 1229,Philippines
Tel: +632 811-0636
Web: http://www.multicare.com.ph/
Multicare Pharmaceuticals Philippines engages in developing, producing, and selling pharmaceutical products in Europe and the United States. The company was founded in 1998 and as of March 26, 2009, Multicare Pharmaceuticals Philippines Inc. operates as a subsidiary of Lupin Ltd.
It offers prescription, over the counter, and nutrition and wellness tablets, capsules, and suspensions. The company provides products in the areas of pain, analgesia, and iron deficiency.
Francis del Val, President & Managing Director of GSK, Philippines, talks about his experience working in the pharmaceutical and healthcare sector in the Philippines, and discusses at length the company’s…
The Country President of AstraZeneca Philippines discusses the company’s new growth strategy, the need for affordable product pricing, and the growing knowledge initiatives the companies is producing in order to…
Sanjay Singh, General Manager of Torrent in the Philippines, talks about the decision behind entering the Philippine market, the company’s strategy for increasing the influence of Indian pharmaceutical companies in…
Patrick Tête, Managaing Director of Servier Philippines, speaks about the differences between running the company in Australia and in the Philippines, that the office and company culture is very similar,…
Dr. Enrique T. Ona, Secretary of Health, Philippines, speaks about PhilHealth, the ambitious universal healthcare system in the Phillipines, why they have not yet reached the estimated number of beneficiaries,…
Executive Director, Teodoro B. Padilla, and Reiner W. Gloor, Adviser of Pharmaceutical & Healthcare Association of the Philippines (PHAP) argue that certain government initiatives, like discounted prices for senior citizens…
Thomas Weigold, President & Managing Director of Novartis Healthcare Philippines expounds upon the rapidly developing healthcare system in the Philippines, what is yet left to improve upon and how Novartis…
Lloyd D. Balajadia, Executive Director of Lloyd Laboratories talks about the advantages and disadvantages of the recent spike in generic medicine within the Philippine market, why despite a contract manufacturer…
Christine Marie D. Rosal, Country Manager of Novo Nordisk Pharmaceuticals (Philippines) gives a startling image of the current state of diabetes in the Philippines, the major reasons behind the soaring…
You have been involved with Lundbeck since the beginning of its operations in the Philippines. How has the company evolved since you joined seven years ago to be where it…
Ms Balajadia, you founded Lloyd Laboratories in 1989. What was the driving force behind the establishment of the company? Truth is, when we started on our first business venture way…
Mr. Chang, can you please give an overview of the establishment of OEP Philippines and the company’s current activities here? OEP Philippines started by acquiring the operations of Elan Pharma…
See our Cookie Privacy Policy Here
